Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis.
Barjot
P
P
Department of Obstetrics and Gynecology, University Hospital of Caen, France.
Hamel
P
P
Calmelet
P
P
Maragnes
P
P
Herlicoviez
M
M
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005424:Flecainide / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D015160:Hydrops Fetalis / Q000150:complications*; D011247:Pregnancy; D011256:Pregnancy Outcome; D013617:Tachycardia, Supraventricular / Q000175:diagnosis / Q000188:drug therapy* / Q000196:embryology; D016216:Ultrasonography, Prenatal
D000889:Anti-Arrhythmia Agents; D005424:Flecainide